Credo Life Science
Posted on 27th January 2022
Advantages of Working with a Leading Itraconazole Pellets Manufacturer
Itraconazole, a broad-spectrum triazole antifungal, presents significant formulation challenges due to its extremely poor aqueous solubility (BCS Class II drug). Overcoming these challenges requires an Itraconazole Pellets Manufacturer with deep expertise in solubility enhancement technologies, particularly the hot melt extrusion (HME) or layering techniques used to produce high-bioavailability pellets.
The Formulation Challenge: Why Itraconazole Needs Pellets
Itraconazole has practically negligible aqueous solubility, making conventional tablet or capsule formulations ineffective. Drug bioavailability is dramatically enhanced when Itraconazole is converted into pellets using solid dispersion technology — dispersing the drug in a hydrophilic polymer matrix to increase dissolution and absorption. This is why the pellet-based formulation is the gold standard for Itraconazole.
Key Advantages of Partnering with an Itraconazole Pellets Manufacturer
- Solubility Enhancement Expertise: A specialised manufacturer employs validated techniques such as polymer-based solid dispersion to maximise drug bioavailability.
- Precision Particle Engineering: Uniform pellet size, narrow size distribution, and consistent drug loading are hallmarks of a quality manufacturer.
- Flexible Fill Options: Itraconazole pellets can be filled into hard gelatin capsules, HPMC capsules, or compressed into MUPS tablets — a capable manufacturer supports all configurations.
- Bioavailability Comparison Data: A leading manufacturer will provide in vitro dissolution profiles comparable to the reference brand (Sporanox), facilitating regulatory bioequivalence submissions.
- Scale-Up Capability: From development batches to full commercial production, your manufacturing partner should demonstrate consistent scale-up without quality compromise.
Technology at the Heart of Itraconazole Pellet Manufacturing
At Credo Life Sciences, we use a proven drug layering and polymer dispersion approach to manufacture Itraconazole pellets. Our process utilises MCC sugar spheres as starter beads, onto which Itraconazole is layered using validated spray suspension methods. An HPMC-based film coat improves moisture resistance, and the result is a free-flowing pellet with excellent drug content uniformity.
Regulatory and Quality Support
Our Itraconazole Pellets are manufactured in our WHO-GMP certified facility with comprehensive documentation — batch records, in-process test results, CoA, and ICH-compliant stability data. We also support our partners with regulatory submissions in multiple markets, including EU CTD, ANDA, and WHO-PQ dossiers.
Working with a leading Itraconazole Pellets Manufacturer like Credo Life Sciences ensures that your antifungal product reaches patients with the bioavailability, quality, and regulatory compliance it demands. Reach out to our technical team to discuss your requirements.